Greece Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

Greece’s infection control market is evaluated at US$50.692 million for the year 2020 and is projected to grow at a CAGR of 5.47% to reach a market size of US$ 73.608 million by the year 2027. According to estimates, market growth will be boosted throughout the projection period by the higher incidence of smoking-related health issues in Greece. The surge in the occupancy of medical beds in private hospitals is further providing provides an opportunity for the market to thrive in the forecast period. There is a presence of smaller outpatient clinics in rural areas that are in collaboration with bigger public hospitals, hence so it becomes easier to access faster Over the next five years, the market demand for these outpatient clinics will increase due to emergency treatments. Furthermore, with investments in the pharmaceutical industry in Greece along with the growing number of clinical trials resulting in the development of novel drugs, the market is projected to be fueled in the forecast period and in the coming years.

Given the prevalence of smoking-related disorders and the rising number of treatments available for them, the market is expected to rise during the forecast period.

Non-communicable diseases, such as cancer, chronic respiratory illnesses, and cardiovascular disorders, are said to be the main cause of death in Greece. Lung cancer is one of the malignancies that smoking is thought to have caused in the nation. As the majority of cancer cases were observed to also have a smoking history, a study found a strong association between lung cancer and heavy smoking. The percentage of mortality due to trachea, bronchus,  COPD, and lung cancer in the European region has increased as a result of this. Furthermore, it is estimated that this trend will continue to increase until 2030. Hence, smoking, which is considered to be the ultimate cause for of these mortalities in Greece, especially non-communicable respiratory diseases, will continue to cause have a significant impact on public health and health expenditure. With rising hospital admissions for the management and therapy of these semi-diseases at various disease stages, however, the market for infection control will continue to soar in the forecast period and in the approaching years due to the prevalence of smoking-related ailments.

The growing investments in the life sciences and pharma industry industries are is further providing an opportunity for the market to thrive in the forecast period.

Greece has reputable manufacturing and research and development facility. Hence this is providing strong growth potential for the life sciences and pharmaceutical industries to thrive in the forecast period and in the upcoming years. The life sciences sector in this country is expanding quickly, with numerous spin-off businesses relentlessly pursuing international R&D partnerships in order to create reliable, technologically advanced goods and services that will further fuel market expansion over the forecast period and in the following years. Additionally, Greece's pharmaceutical industry, which is geared toward domestic consumption, makes a significant economic contribution to the nation. The Greek research and development infrastructure, including the world-renowned research institutes, research teams, and University university, research groups, are further adding to the strong growth of the life sciences industry.

COVID-19 SCENARIO

The market for infection control in Greece has been significantly impacted by the COVID-19 epidemic. Worldwide healthcare systems have been devastated by the pandemic, with hospitals becoming overcrowded as patient numbers rise. Temporary hospitals are being built to handle the influx of cases. The spread of COVID-19 has caused a boom in demand for cleaning and disinfection products because of the heightened awareness about cleanliness, health, and safety. However, it is anticipated that the infection control business will suffer severely in the post-COVID situation.

Key Development

• January 2021- By forming new cooperation with Lifecyn S.A. (Lifecyn) in Greece, Bactiguard is able to continue the introduction of the Hydrocyn® aqua (Hydrocyn) product line in Europe. The partnership is based on an exclusive distribution contract for the Hydrocyn® aqua line of advanced disinfection and wound care products from Bactiguard.

Greece Infection Control Market Scope:

Market Segmentation:

• By Product
  • Disinfectant
  • Sterilization
    • Low temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical